Management

Chief Executive Officer

Ms. Kuo has been our director since December 2018. She currently serves as our chairwoman of the board of directors and chief executive officer. Ms. Kuo is the founder of Health Ever Bio-Tech Co., Ltd. She has also been serving as the Chairwoman and CEO of Genvace Biotechnology Co., Ltd. and Zhao Jian Fu Co., Ltd. since 2021 and 2011, respectively. Ms. Kuo has over 30 years of experience in the R&D of botanical products and new drugs and used to own multiple global patents in compositions. Since the establishment of Health Ever Bio-Tech Co., Ltd., or HEB, in 2002, Ms. Kuo has painstakingly researched and established CMC data, led HEB’s conferences with regulatory authorities, and highly participated in preclinical studies as well as clinical trials of new drug candidates, such as Phase III clinical trials on MCS-2 in the U.S. and Taiwan. Ms. Kuo had already initiated her research on natural medicine formulations before establishing HEB. During her study in the U.S., Ms. Kuo focused on developing new drugs for the treatment of urinary system diseases, formulated a preliminary blueprint, and began to explore active ingredients from plants. From 1996 to 1997, Ms. Kuo previously served as the guest lecturer on special nutritional foods in various hospitals in Taiwan. From 1987 to 1996, Ms. Kuo established Panatoz Corporation, a company engaging in international trade of health care products and plant raw materials and served as the Chairwoman as well as the general manager. Ms. Kuo received a master’s degree in business management from Dominican University of California in 2000.

Chief Financial Officer

Mr. Ying will serve as our chief financial officer upon the effectiveness of our registration statement on Form F-1 of which this prospectus is a part. Mr. Ying has over 20 years of experience in capital markets as well as extensive knowledge in corporate finance, capital raising, finance and accounting. Mr. Ying has been serving as the chief financial officer of Health Ever Bio-Tech Co., Ltd. since July 2022 and he used to serve in this position from November 2018 to November 2020. Mr. Ying previously worked as the chief strategy officer of BlueCity Holdings Limited from July 2021 to June 2022. He also served as the chief financial officer of iFresh, Inc. from May 2017 to March 2018, the director of investor relations at Safe-Run Machinery (Suzhou) Co., Ltd. from December 2015 to November 2016, and the vice president of equity research at Piper Jaffray Asia Securities Limited from September 2011 to September 2014. Before joining Piper Jaffray, Mr. Ying served as the vice president of investor relations and M&A at Daphne International Holdings Limited from August 2007 to March 2011, and the research director of BNP Paribas Peregrine Securities (Taiwan) Co., Ltd. from October 2000 to December 2004. Mr. Ying received a master’s degree in business administration from the University of New South Wales in Australia in 1995, a master’s degree in mechanical engineering from the National Chiao Tung University in Taiwan in 1989, and a bachelor’s degree in mechanical engineering from the National Cheng Kung University in Taiwan in 1987.

Chief Technology Officer

Dr. Hsu will serve as our director and chief technology officer upon the effectiveness of our registration statement on Form F-1 of which this prospectus is a part. Dr. Hsu has been serving as the chief technology officer of Health Ever Bio-Tech Co., Ltd. since July 2021. He is an expert in the research of natural medicinal chemistry, the R&D of Chinese herbal medicine, and the management of biotechnology medicine R&D. Prior to joining us, Dr. Hsu served as deputy editor-in-chief for Journal of Food and Drug Analysis, the director and consultant of NatureWise Biotech & Medicals Corporation from 2018 to 2021. Dr. Hsu served as the professor fellow for China Industrial & Commercial Research Institute and deputy editor-in-chief for Journal of Food and Drug Analysis from 2015 to 2018. Dr. Hsu served as a professor at Taipei Medical College (currently known as Taipei Medical University) from 1993 to 2014, and was awarded an Honorary Professorship in 2015. From 1993 to 2003, Dr. Hsu also served as the director of the Pharmacy Department of Taipei Medical College Hospital, where he engaged in drug management and clinical pharmacy. From 2000 to 2010, Dr. Hsu served as the director of Graduate Institute of Pharmacognosy at Taipei Medical College where he was responsible for the daily management of the Institute. Dr. Hsu received a Ph.D. in pharmaceutical sciences in 1985 and a master’s degree in pharmaceutical sciences in 1982 from Kyushu University in Japan. Dr. Hsu has been a qualified pharmacist in Taiwan since 1949.

Chief Science Officer

Dr. Su will serve as our chief science officer upon the effectiveness of our registration statement on Form F-1 of which this prospectus is a part. Dr. Su has been the chief science officer of Health Ever Bio-Tech Co., Ltd. since December 2020. From 2007 to 2020, Dr. Su served as the clinical assistant professor at Taipei Medical University. From 2008 to 2009, Dr. Su served as the project manager of the Clinical Trials Center at Taipei Municipal Wan Fang Hospital, where she focused on managing clinical trials and coordination. Dr. Su received a diploma in aromatherapy from the International Federation of Aromatherapists in 2019, a bachelor’s degree of science in pharmacy from Northeastern University in 2004, and a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences in 1998. She has been an international clinical member and an international level 3 NAHA certified clinical aromatherapist of the National Association for Holistic Aromatherapy since 2020, and a registered full member of the International Federation of Aromatherapists since 2019. In 2005, Dr. Su became a holistic health counselor certified by Institute for Integrative Nutrition and was recognized as an expert in the health field as a Holistic Health Practitioner. Dr. Su has been a registered pharmacist in the state of Massachusetts since 1999 and a qualified pharmacist in Taiwan since 2008.